Prostatic intraepithelial neoplasia: an update

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• High-grade prostatic intraepithelial neoplasia (HGPIN) is a common finding in prostate needle biopsies.
• HGPIN is considered the most significant risk factor for prostate cancer and likely represents its premalignant phase.
• This lesion shares cellular similarities with prostate cancer but retains a basal cell layer.

Purpose of the Study:

• To highlight the significance of HGPIN as a precursor to prostate cancer.
• To emphasize the diagnostic criteria and implications of HGPIN detection.
• To discuss the association of HGPIN with prostate cancer risk and management strategies.

Main Methods:

• Review of epidemiological, molecular, and animal models linking HGPIN to prostate cancer.
• Immunohistochemical analysis using cytokeratin 34bE12 to identify the basal cell layer in HGPIN.
• Analysis of large series data correlating HGPIN detection on initial biopsy with subsequent cancer diagnosis.

Main Results:

• HGPIN incidence increases with age, found in up to 25% of biopsies, and coexists with prostate cancer in ~85% of cases.
• No causal relationship observed between HGPIN and serum PSA levels or transrectal ultrasound characteristics.
• HGPIN on initial biopsy is associated with a ~35% risk of prostate cancer on subsequent biopsies.

Conclusions:

• HGPIN is a critical precursor lesion for prostatic adenocarcinoma.
• Detection of HGPIN mandates a follow-up biopsy for eligible patients.
• HGPIN serves as a target for chemopreventive strategies, including antiandrogens and nutritional supplements.